Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fortin

Showing results (161-170 of 329) with videos related to

Pageof 33
Sort By:
Nature|January 18, 1990
Identification and isolation of a membrane protein necessary for leukotriene productionD K Miller, J W Gillard, P J Vickers, et al.
The Journal of Rheumatology|December 4, 2009
The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosusElaheh Aghdassi, Stacey Morrison, Carolina Landolt-Marticorena, et al.
JMIR Research Protocols|June 1, 2016
Development of the Lupus Interactive Navigator as an Empowering Web-Based eHealth Tool to Facilitate Lupus Management: Users Perspectives on Usability and AcceptabilityCarolyn Neville, Deborah Da Costa, Murray Rochon, et al.
The Journal of Rheumatology|June 5, 2012
Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosusJennifer J Y Lee, Elaheh Aghdassi, Angela M Cheung, et al.
Rheumatology (Oxford, England)|December 26, 2016
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenuesNicolas Richard, Marie Hudson, Geneviève Gyger, et al.
Arthritis and Rheumatism|October 23, 2001
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusJ M Esdaile, M Abrahamowicz, T Grodzicky, et al.
Rheumatology (Oxford, England)|September 7, 2014
Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosusTimothy Li, Stephenie D Prokopec, Stacey Morrison, et al.
Arthritis and Rheumatism|April 21, 2011
Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodiesMélanie Dieudé, José A Correa, Carolyn Neville, et al.
The Journal of Rheumatology|February 24, 2000
Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosusD Da Costa, P L Dobkin, M A Fitzcharles, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosusMatthew H Liang, Julia F Simard, Karen Costenbader, et al.
Pageof 33

Showing results (161-170 of 329) with videos related to

Sort By:
Pageof 33
Nature|January 18, 1990
Identification and isolation of a membrane protein necessary for leukotriene productionD K Miller, J W Gillard, P J Vickers, et al.
The Journal of Rheumatology|December 4, 2009
The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosusElaheh Aghdassi, Stacey Morrison, Carolina Landolt-Marticorena, et al.
JMIR Research Protocols|June 1, 2016
Development of the Lupus Interactive Navigator as an Empowering Web-Based eHealth Tool to Facilitate Lupus Management: Users Perspectives on Usability and AcceptabilityCarolyn Neville, Deborah Da Costa, Murray Rochon, et al.
The Journal of Rheumatology|June 5, 2012
Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosusJennifer J Y Lee, Elaheh Aghdassi, Angela M Cheung, et al.
Rheumatology (Oxford, England)|December 26, 2016
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenuesNicolas Richard, Marie Hudson, Geneviève Gyger, et al.
Arthritis and Rheumatism|October 23, 2001
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusJ M Esdaile, M Abrahamowicz, T Grodzicky, et al.
Rheumatology (Oxford, England)|September 7, 2014
Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosusTimothy Li, Stephenie D Prokopec, Stacey Morrison, et al.
Arthritis and Rheumatism|April 21, 2011
Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodiesMélanie Dieudé, José A Correa, Carolyn Neville, et al.
The Journal of Rheumatology|February 24, 2000
Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosusD Da Costa, P L Dobkin, M A Fitzcharles, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosusMatthew H Liang, Julia F Simard, Karen Costenbader, et al.
Pageof 33